Binciken da Young, MD, Anderson Cancer Center, Amurka suka rubuta sun bayyana yadda ake amfani da PD-1 inhibitor immunotherapy a cikin B-cell lymphoma. (Jini. Sigar kan layi a ranar Nuwamba 8, 2017. Doi: 10.1182 / jini-2017-07-740993.) PD-1 immunity ..
Cleveland Clinic na Amurka Eric D. His et al. Ya yi rahoton cewa ganewar asirin T cell lymphoma (PTCL) a cikin Amurka ya bambanta ƙwarai, kuma sau da yawa ba shi da mahimman bayanai masu mahimmanci don rarrabewa sosai ..
Ciwon ƙwayar T-cell mai girma, irin su lymphoma na T-cell ba na Hodgkin ba, suna da haɗari sosai kuma suna da tsayayyar magani, kuma marasa lafiya galibi suna da mummunan hangen nesa. Kwanan nan, "Yanayi" jerin labaran guda biyu sun buga sabon fassarar kwayar cutar ..
Kiba ba wai kawai yana cin karo da kyawawan halaye na mutane ba, har ma yana haifar da cututtuka masu yawa. Wasu bincike sun nuna cewa ma'aunin jiki (BMI) yana da alaƙa da haɗarin ciwon daji a wasu sassa (kamar tsarin narkewar abinci), ...
Jiya, FDA ta Amurka ta ba da sanarwar amincewa da kwayar cutar kwayar cutar ta Seattle Genetics 'conjugate Adcetris (brentuximab vedotin) a hade tare da cutar sankara ga marasa lafiya tare da matakin da aka yi wa magani na III ko kwayar cutar Hodgkin ta yau da kullun ..
Sabon binciken asibitin Cleveland ya nuna a karo na farko cewa ibrutinib da aka amince da shi na FDA (ibrutinib) na kwayar cutar lymphoma da leukemia na iya taimakawa wajen kula da cututtukan kwakwalwa da suka fi saurin mutuwa, kuma wata rana za a yi amfani da marasa lafiya da gliobla ..
Rosiswayar ƙwayar kasusuwa cuta ce mai saurin ciwan ƙwayoyin cuta na ƙwayoyin cuta na hematopoietic. Suna fa'ida daga magungunan hana JAK2: saukaka alamomi, rayuwa mai tsawo, da ingantaccen rayuwa. Koyaya, shekaru biyu ko uku bayan farawa ..
A ranar 12-13 ga Yuni, FDA ta amince da sabbin alamomi guda biyu don maganin K, kwana daya kacal kafin a amince da maganin K don magance cutar sankarar mahaifa. Wata rana daga baya, FDA ta Amurka ta amince da pembrolizumab (Keytruda, pembrolizumab) don trea ..
A Amurka, sama da mutane 70,000 ake kamuwa da cutar lymphoma wacce ba ta Hodgkin ba a kowace shekara, wanda hakan ke faruwa ne sakamakon yawaitar kwayoyin halittar garkuwar jiki a sassan jiki na lymph. Mafi na kowa shi ne yada babban B-cell lymp ..
A cikin 'yan shekarun nan, tasirin masu hana kariya daga bincike kan cutar lymphoma na Hodgkin (HL) abin birgewa ne, amma har yanzu ana bukatar shawo kan cutar sosai. Shugaban Kamfanin Mayo Clinic na Lymphoma Group Ansell sai ..